DNAzyme

From Aaushi
Jump to navigation Jump to search

Mechanism of action

More general terms

More specific terms

References

  1. Cho E-A et al. Safety and tolerability of an intratumorally injected DNAzyme, Dz13, in patients with nodular basal-cell carcinoma: A phase 1 first-in-human trial (DISCOVER). Lancet 2013 May 25; 381:1835 PMID: https://www.ncbi.nlm.nih.gov/pubmed/23660123
    Grassi G and Grassi M. First-in-human trial of Dz13 for nodular basal-cell carcinoma. Lancet 2013 May 25; 381:1797. PMID: https://www.ncbi.nlm.nih.gov/pubmed/23660122